CNS Neuroscience & Therapeutics · 2023 · 29 citations · 45 references
MedicineImmunologyOncologyMolecular OncologyTumor ImmunologyTumor MicroenvironmentCancer ProteomicsCancer TranscriptomicsMolecular Tumor ProfilingTumor Immune MicroenvironmentTumor Microenvironment InteractionsTumor-associated MacrophagesCancer Signaling PathwaysCell Atlas ConstructionImmune Microenvironment AnalysisImmunohistochemical StainingSingle-cell Rna SequencingSingle-cell Rna Sequencing Cell Type AnnotationTumor Immune Microenvironment ProfilingTumor-associated Macrophage Interactions
AIMS: Tumor-associated macrophages (TAMs) in the immune microenvironment play an important role in the increased drug resistance and recurrence of malignant glioma, but the mechanism remains incompletely inventoried. The focus of this study was to investigate the distinctions of M2-like TAMs in the immune microenvironment between primary and recurrent malignant glioma and its influence in the recurrence. METHODS: We employed single-cell RNA sequencing to construct a single-cell atlas for a total of 23,010 individual cells from 6 patients with primary or recurrent malignant glioma and identified 5 cell types, including TAMs and malignant cells. Immunohistochemical techniques and proteomics analysis were performed to investigate the role of intercellular interaction between malignant cells and TAMs in the recurrence of malignant glioma. RESULTS: Six subgroups of TAMs were annotated and M2-like TAMs were found to increase in recurrent malignant glioma significantly. A pseudotime trajectory and a dynamic gene expression profiling during the recurrence of malignant glioma were reconstructed. Up-regulation of several cancer pathways and intercellular interaction-related genes are associated with the recurrence of malignant glioma. Moreover, the M2-like TAMs can activate the PI3K/Akt/HIF-1α/CA9 pathway in the malignant glioma cells via SPP1-CD44-mediated intercellular interaction. Interestingly, high expression of CA9 can trigger the immunosuppressive response in the malignant glioma, thus promoting the degree of malignancy and drug resistance. CONCLUSION: Our study uncovers the distinction of M2-like TAMs between primary and recurrent glioma, which offers unparalleled insights into the immune microenvironment of primary and recurrent malignant glioma.
45
Universal sample preparation method for proteome analysis
Jacek R. Wiśniewski, Alexandre Zougman, Nagarjuna Nagaraj et al. · Nature Methods · 2009 · 8.7K citations
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel, Julie Laffy, Mariella G. Filbin et al. · Cell · 2019 · 2.9K citations · Full text
Medicine, Cancer Biology, Genetics +14